Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.

The development of familial and sporadic breast cancer is based on genetic alterations of tumour-suppressor genes, for which loss of heterozygosity (LOH) is one mechanism of gene inactivation. To investigate LOH of BRCA1 (17q21) and BRCA2 (13-q12-13) in sporadic breast cancer, polymerase chain react...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckmann, M. W., Picard, F., An, H. X., van Roeyen, C. R., Dominik, S. I., Mosny, D. S., Schnürch, H. G., Bender, H. G., Niederacher, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074503/
https://www.ncbi.nlm.nih.gov/pubmed/8630282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074503/
https://www.ncbi.nlm.nih.gov/pubmed/8630282

Ejemplares similares